SCHEMBL23905494

SCHEMBL23905494

CC1(CF)COc2c1cc(C(O)(CN)C(F)(F)F)nc2-c1ccc(F)cc1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CFTR P13569 3/20 0.32
CYP2C9 P11712 1/20 0.30
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905398 1.00 CFTR (0.32) CFTRCYP2C9IDO1
SCHEMBL23904863 1.00 CFTR (0.32) CFTRCYP2C9IDO1
SCHEMBL23904787 0.92 CYP2C9 (0.32) CFTRCYP2C9IDO1
SCHEMBL23905493 0.92 CYP2C9 (0.33) CFTRCYP2C9IDO1
SCHEMBL23904890 0.90 PTGS2 (0.33) CFTR
SCHEMBL23904751 0.89 CFTR (0.30) CFTR
SCHEMBL18031466 0.88 CFTR (0.32) CFTR
SCHEMBL23905787 0.88 CFTR (0.32) CFTR
SCHEMBL23905456 0.88
SCHEMBL23904793 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed